1. Home
  2. GAME vs HOWL Comparison

GAME vs HOWL Comparison

Compare GAME & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameSquare Holdings Inc.

GAME

GameSquare Holdings Inc.

N/A

Current Price

$2.48

Market Cap

43.4M

Sector

N/A

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

N/A

Current Price

$0.98

Market Cap

46.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GAME
HOWL
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.4M
46.7M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
GAME
HOWL
Price
$2.48
$0.98
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $11.33
N/A
AVG Volume (30 Days)
78.3K
★ 322.8K
Earning Date
11-16-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.14
18.40
EPS
N/A
★ N/A
Revenue
★ $44,999,302.00
N/A
Revenue This Year
$91.12
N/A
Revenue Next Year
$47.60
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.24
$0.27
52 Week High
$3.85
$1.20

Technical Indicators

Market Signals
Indicator
GAME
HOWL
Relative Strength Index (RSI) 41.42 47.43
Support Level $0.32 $0.88
Resistance Level $2.84 $0.99
Average True Range (ATR) 0.19 0.06
MACD 0.00 -0.01
Stochastic Oscillator 39.71 17.33

Price Performance

Historical Comparison
GAME
HOWL

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: